In consistent with above statement, CA10 treatment reduced the protein expression of CDC2, Cyclin B1 and MDM2, this further emphasizes that CA10 can inhibit the aggressive potential of gastric cancer cells through G2/M cycle arrest. Here, CCNB1 is linked to gastric cancer.